Scott Montgomery - Institutionen för medicinska vetenskaper

552

Sökning - Publikationer - Forskning.fi

WEITERE INFOS. Info. www.haematologica.org publishes novel findings in basic, clinical and translational hematology research. Impact Factor (JCR) 7.116 (7th  April, 2021. No. 106 (4). TABLE OF CONTENTS; DOWNLOAD THE ISSUE; ABOUT THE COVER.

  1. Starta program
  2. Familjejuristen malmö
  3. Sales chef
  4. Skönvik folkhögskola
  5. Tandläkare hässleholm hanna sowiak
  6. Mts filformat
  7. Vårdcentralen viksjö capio
  8. Vad ar reflex

Talidomid. The 3-year survival rate increased with 34% (95% CI 19-49), in thalidomide-treated patients in Haematologica. 2002;87(3):327-8. Lancaster S, Chrisp P. Bortezomib: The evidence of its clinical impact in multiple myeloma. Core. av CL Loprinzi · Citerat av 7 — The incidence, risk factors, pathogenetic mechanisms, and clinical characteristics of CIPN in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline. Haematologica 2012; 97:1925.

Sf Bio Skaraborg - Canal Midi

ISSN: 0939-5555. haematologica (adjective, plural and neuter, used as a noun) = hematological subjects the hematology journal 2003 JCR® Impact Factor = 3.453 Haematologica/The Hematology Journal, as the official organ of the European Hematology Association (EHA), aims not only to serve the scientific community, but also to promote European cultural identity. This high level has been maintained in 2014. Since 2010, Haematologica has been within the top 10 of hematology journals, with a stable Impact Factor around   Acta Haematologica.

V64 resultat torsdag - conditionals.pagoad.site

2011, 0.588.

Haematologica impact factor

Haematologica Impact Factor for the years 1982–2018. An external file that holds a  Read 1100 articles with impact on ResearchGate, the professional network for multiple myeloma, hereditary disorders, blood coagulation, growth factors,  2012 Impact Factor List. Date: 28th April, 2014. citefactor-journal-indexing URL : http://www.haematologica.org.
Handledare bilkörning

Haematologica impact factor

= [(7.53-7.73))/(7.73)] X 100 = -2.59% The impact factor (IF) 2018 of Haematologica is 7.53, which is computed in 2019 as per it's definition. Haematologica IF is decreased by a factor of 0.2 and approximate percentage change is -2.59% when compared to preceding year 2017, which shows a falling trend. With a 2015 impact factor of 6.671, from Journal Citation Reports, Haematologica ranked 4th out of 70 journals in the "Hematology" category and it is also indexed in the following databases: Pubmedcentral International Scientific Journal & Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals The Impact Factor continued to grow and in 2006 had reached 5.032 .

Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. Haematologica’s impact factor.
Demokrati regelbok

Haematologica impact factor civilekonomutbildningar sverige
hr traineeship
författare birgitta lindqvist
grundad teori motivation
kg urmakeri folkungagatan
privat gymnasium helsingborg

PDF Pharmacogenetic study of the impact of ABCB1 single

Acta Haematologica Impact Factor 2018-2019 The impact factor (IF) 2018 of Acta Haematologica is 1.47 , which is computed in 2019 as per it's definition.

Haematologica-The Hematology Journal - Research Outputs

Acta Haematologica | Citations: 1,507 | Acta Haematologicaí is a well-established and internationally recognized journal featuring balanced, wide-ranging coverage of current hematology research. One hundred years of Haematologica Paolo Mazzarello; Department of Brain and Behavioral Sciences and University Museum System, University of Pavia, Italy. Vol. 105 No TY - JOUR. T1 - Haematologica's impact factor.

relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age. Blood. 2003  Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients (P = 0.046), and also significant differences in the rate of Haematologica 92(2):277–278. av MG till startsidan Sök — TINF2, 14q12, TERF1-interacting nuclear factor 2, Shelterin, AD, DC, HHS Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the Haematologica 2016; 101: 1180-1189.